University Hospital Bratislava
- Address
- lock Available on a paid plan
University Hospital Bratislava - Multispecialty Clinical Research Center
University Hospital Bratislava is a leading academic medical center conducting advanced clinical research across multiple therapeutic areas. The institution demonstrates particular expertise in neurovascular medicine, ophthalmology, and innovative treatments for neurological and musculoskeletal disorders. As a comprehensive research facility, the hospital participates in pivotal Phase 3 trials evaluating novel therapeutics and treatment strategies for conditions affecting diverse patient populations.
- Acute ischemic stroke and transient ischemic attack prevention, including trials of novel anticoagulant agents
- Retinal diseases and macular edema secondary to vascular occlusions requiring intravitreal therapies
- Multiple sclerosis treatments and long-term safety monitoring of disease-modifying therapies
- Musculoskeletal conditions including rotator cuff tendinopathy and infectious disease management
The center's research portfolio reflects a commitment to evaluating both neuroprotective strategies for cerebrovascular disease and advanced biologics for inflammatory conditions. With expertise spanning from complicated urinary tract infections to chronic neurological disorders, University Hospital Bratislava serves as a critical site for establishing new treatment paradigms and comparing novel oral formulations to standard intravenous therapies across multiple disease states.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in University Hospital Bratislava
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis | F. Hoffmann-La Roche AG | Phase II | Not Recruiting | Jan 2022 | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.